[HTML][HTML] Prognostic value of des-γ-carboxy prothrombin in patients with hepatocellular carcinoma treated with transarterial chemotherapy: A systematic review and …
M Yang, X Zhang, J Liu - PLoS One, 2019 - journals.plos.org
Background Serum des-γ-carboxy prothrombin (DCP) is a hepatocellular carcinoma (HCC)
tumor marker that can be used to assess patient prognosis. Since the value of DCP in …
tumor marker that can be used to assess patient prognosis. Since the value of DCP in …
Prognostic value of des-γ-carboxy prothrombin in patients with hepatocellular carcinoma treated with transarterial chemotherapy: A systematic review and meta …
M Yang, X Zhang, J Liu - PLOS ONE, 2019 - econpapers.repec.org
Background: Serum des-γ-carboxy prothrombin (DCP) is a hepatocellular carcinoma (HCC)
tumor marker that can be used to assess patient prognosis. Since the value of DCP in …
tumor marker that can be used to assess patient prognosis. Since the value of DCP in …
[HTML][HTML] Prognostic value of des-γ-carboxy prothrombin in patients with hepatocellular carcinoma treated with transarterial chemotherapy: A systematic review and …
M Yang, X Zhang, J Liu - PLoS ONE, 2019 - ncbi.nlm.nih.gov
Background Serum des-γ-carboxy prothrombin (DCP) is a hepatocellular carcinoma (HCC)
tumor marker that can be used to assess patient prognosis. Since the value of DCP in …
tumor marker that can be used to assess patient prognosis. Since the value of DCP in …
Prognostic value of des-[gamma]-carboxy prothrombin in patients with hepatocellular carcinoma treated with transarterial chemotherapy: A systematic review and …
M Yang, X Zhang, J Liu - PLoS ONE, 2019 - go.gale.com
Prognostic value of des-[gamma]-carboxy prothrombin in patients with hepatocellular
carcinoma treated with transarterial chemotherapy: A systematic review and meta-analysis …
carcinoma treated with transarterial chemotherapy: A systematic review and meta-analysis …
[引用][C] Prognostic value of des-γ-carboxy prothrombin in patients with hepatocellular carcinoma treated with transarterial chemotherapy: A systematic review and meta …
M Yang, X Zhang, J Liu - PLoS ONE, 2019 - ui.adsabs.harvard.edu
Prognostic value of des-γ-carboxy prothrombin in patients with hepatocellular carcinoma
treated with transarterial chemotherapy: A systematic review and meta-analysis - NASA/ADS …
treated with transarterial chemotherapy: A systematic review and meta-analysis - NASA/ADS …
Prognostic value of des-γ-carboxy prothrombin in patients with hepatocellular carcinoma treated with transarterial chemotherapy: A systematic review and meta …
M Yang, X Zhang, J Liu - PloS one, 2019 - pubmed.ncbi.nlm.nih.gov
Background Serum des-γ-carboxy prothrombin (DCP) is a hepatocellular carcinoma (HCC)
tumor marker that can be used to assess patient prognosis. Since the value of DCP in …
tumor marker that can be used to assess patient prognosis. Since the value of DCP in …
Prognostic value of des-γ-carboxy prothrombin in patients with hepatocellular carcinoma treated with transarterial chemotherapy: A systematic review and meta …
M Yang, X Zhang, J Liu - PLoS ONE, 2019 - search.ebscohost.com
Background: Serum des-γ-carboxy prothrombin (DCP) is a hepatocellular carcinoma (HCC)
tumor marker that can be used to assess patient prognosis. Since the value of DCP in …
tumor marker that can be used to assess patient prognosis. Since the value of DCP in …
Prognostic value of des-γ-carboxy prothrombin in patients with hepatocellular carcinoma treated with transarterial chemotherapy: A systematic review and meta …
M Yang, X Zhang, J Liu - PLOS ONE, 2019 - ideas.repec.org
Background: Serum des-γ-carboxy prothrombin (DCP) is a hepatocellular carcinoma (HCC)
tumor marker that can be used to assess patient prognosis. Since the value of DCP in …
tumor marker that can be used to assess patient prognosis. Since the value of DCP in …
Prognostic value of des-γ-carboxy prothrombin in patients with hepatocellular carcinoma treated with transarterial chemotherapy: A systematic review and meta …
M Yang, X Zhang, J Liu - Plos one, 2019 - europepmc.org
Background Serum des-γ-carboxy prothrombin (DCP) is a hepatocellular carcinoma (HCC)
tumor marker that can be used to assess patient prognosis. Since the value of DCP in …
tumor marker that can be used to assess patient prognosis. Since the value of DCP in …
[PDF][PDF] Prognostic value of des-γ-carboxy prothrombin in patients with hepatocellular carcinoma treated with transarterial chemotherapy: A systematic review and meta …
M Yang, X Zhang, J Liu - PLoS ONE, 2019 - pdfs.semanticscholar.org
Background Serum des-γ-carboxy prothrombin (DCP) is a hepatocellular carcinoma (HCC)
tumor marker that can be used to assess patient prognosis. Since the value of DCP in …
tumor marker that can be used to assess patient prognosis. Since the value of DCP in …